Literature DB >> 5353940

Cancer of the breast: size of neoplasm and prognosis.

B Fisher, N H Slack, I D Bross.   

Abstract

Entities:  

Mesh:

Year:  1969        PMID: 5353940     DOI: 10.1002/1097-0142(196911)24:5<1071::aid-cncr2820240533>3.0.co;2-h

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  67 in total

1.  Clinicopathological Characteristics of Non-palpable Breast Cancer Presenting as Axillary Mass.

Authors: 
Journal:  Breast Cancer       Date:  1995-10-31       Impact factor: 4.239

2.  The Nottingham Prognostic Index in primary breast cancer.

Authors:  M H Galea; R W Blamey; C E Elston; I O Ellis
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

3.  Nuclear pleomorphism, a strong prognostic factor in axillary node-negative small invasive breast cancer.

Authors:  M Stierer; H Rosen; R Weber
Journal:  Breast Cancer Res Treat       Date:  1992-01       Impact factor: 4.872

4.  Minimal breast cancer: a clinical appraisal.

Authors:  T G Peters; W L Donegan; E A Burg
Journal:  Ann Surg       Date:  1977-12       Impact factor: 12.969

5.  The relationship between tumour volume and the extent of spread in colorectal carcinoma.

Authors:  K W Scott; R H Grace
Journal:  Int J Colorectal Dis       Date:  1994       Impact factor: 2.571

Review 6.  Current status and indications for adjuvant therapy in breast cancer.

Authors:  H J Senn
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

7.  Occult breast carcinomas detected by xeroradiography: clinical considerations.

Authors:  L J Malone; G Frankl; R A Dorazio; J H Winkley
Journal:  Ann Surg       Date:  1975-02       Impact factor: 12.969

8.  Progesterone binding cyst protein (PBCP) in primary breast cancer: a new prognostic factor?

Authors:  J A Søreide; O A Lea; S Kvinnsland
Journal:  Breast Cancer Res Treat       Date:  1987       Impact factor: 4.872

9.  Immunobiology of operable breast cancer: an assessment of biologic risk by immunoparameters.

Authors:  H J Wanebo; P P Rosen; T Thaler; J A Urban; H F Oettgen
Journal:  Ann Surg       Date:  1976-09       Impact factor: 12.969

10.  Charity Hospital experience with long-term survival and prognostic factors in patients with breast cancer with localized or regional disease.

Authors:  C M Sutherland; F J Mather
Journal:  Ann Surg       Date:  1988-05       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.